$3.59 Billion is the total value of BVF INC/IL's 67 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 23.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $1,109,315,484 | +138.4% | 21,751,284 | 0.0% | 30.92% | +81.8% | ||
| RVMD | Buy | REVOLUTION MEDICINES INC | $167,336,979 | +55.9% | 6,255,588 | +26.2% | 4.66% | +18.9% |
| AXSM | AXSOME THERAPEUTICS INC | $153,140,846 | +16.5% | 2,131,100 | 0.0% | 4.27% | -11.2% | |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $133,561,992 | +296.2% | 5,683,489 | +131.5% | 3.72% | +202.2% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $116,771,995 | +27.6% | 2,846,015 | +11.1% | 3.26% | -2.7% |
| GHRS | GH RESEARCH PLCordinary shares | $110,049,750 | +48.5% | 9,275,158 | 0.0% | 3.07% | +13.2% | |
| KYMR | KYMERA THERAPEUTICS INC | $108,949,702 | -22.4% | 4,739,004 | 0.0% | 3.04% | -40.8% | |
| PTGX | PROTAGONIST THERAPEUTICS INC | $104,290,358 | +20.1% | 3,775,900 | 0.0% | 2.91% | -8.4% | |
| PNT | POINT BIOPHARMA GLOBAL INC | $95,707,557 | +24.6% | 10,563,748 | 0.0% | 2.67% | -5.0% | |
| GLPG | GALAPAGOS NVspon adr | $88,033,332 | +5.2% | 2,165,109 | 0.0% | 2.45% | -19.8% | |
| RPTX | REPARE THERAPEUTICS INC | $87,729,233 | +7.5% | 8,291,988 | 0.0% | 2.44% | -18.0% | |
| STRUCTURE THERAPEUTICS INCsponsored ads | $72,747,500 | +74.7% | 1,750,000 | 0.0% | 2.03% | +33.2% | ||
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $72,413,953 | +5.1% | 4,007,413 | 0.0% | 2.02% | -19.9% | |
| KURA | KURA ONCOLOGY INC | $71,213,800 | -13.5% | 6,730,983 | 0.0% | 1.98% | -34.0% | |
| XENE | XENON PHARMACEUTICALS INC | $70,376,383 | +7.6% | 1,827,958 | 0.0% | 1.96% | -18.0% | |
| OLMA | OLEMA PHARMACEUTICALS INC | $68,731,872 | +160.2% | 7,611,503 | 0.0% | 1.92% | +98.5% | |
| XOMA | XOMA CORP DEL | $68,641,405 | -10.5% | 3,633,743 | 0.0% | 1.91% | -31.8% | |
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $58,329,701 | +60.8% | 9,423,215 | 0.0% | 1.63% | +22.6% | |
| ZYMEWORKS INC | $50,716,800 | -4.4% | 5,870,000 | 0.0% | 1.41% | -27.1% | ||
| REPL | REPLIMUNE GROUP INC | $49,761,296 | +31.5% | 2,143,036 | 0.0% | 1.39% | +0.3% | |
| JANX | Buy | JANUX THERAPEUTICS INC | $48,749,437 | +154.1% | 4,106,945 | +159.0% | 1.36% | +93.9% |
| Sell | TYRA BIOSCIENCES INC | $46,655,303 | -10.4% | 2,739,595 | -15.4% | 1.30% | -31.7% | |
| LXRX | Buy | LEXICON PHARMACEUTICALS INC | $45,789,310 | +16.7% | 19,995,332 | +23.8% | 1.28% | -11.1% |
| MRUS | Sell | MERUS N V | $42,191,719 | -23.0% | 1,602,420 | -46.2% | 1.18% | -41.3% |
| RLAY | RELAY THERAPEUTICS INC | $39,193,744 | -23.7% | 3,120,521 | 0.0% | 1.09% | -41.9% | |
| ALLK | Buy | ALLAKOS INC | $37,724,538 | +39.9% | 8,652,417 | +42.8% | 1.05% | +6.6% |
| ETNB | 89BIO INC | $34,984,618 | +24.4% | 1,846,154 | 0.0% | 0.98% | -5.2% | |
| ACRS | ACLARIS THERAPEUTICS INC | $34,852,958 | +28.2% | 3,360,941 | 0.0% | 0.97% | -2.3% | |
| CGEM | CULLINAN ONCOLOGY INC | $34,396,503 | +5.2% | 3,196,701 | 0.0% | 0.96% | -19.7% | |
| ITOS | ITEOS THERAPEUTICS INC | $23,975,455 | -2.7% | 1,810,835 | 0.0% | 0.67% | -25.9% | |
| EPIX | ESSA PHARMA INC | $23,621,298 | -9.1% | 8,748,629 | 0.0% | 0.66% | -30.7% | |
| OVID | OVID THERAPEUTICS INC | $22,471,447 | +27.1% | 6,851,051 | 0.0% | 0.63% | -3.1% | |
| ACIU | AC IMMUNE SA | $21,950,860 | +26.3% | 7,428,379 | 0.0% | 0.61% | -3.6% | |
| THIRD HARMONIC BIO INC | $21,000,138 | +16.7% | 4,365,933 | 0.0% | 0.58% | -11.1% | ||
| IKNA | IKENA ONCOLOGY INC | $20,789,716 | +90.1% | 3,169,164 | 0.0% | 0.58% | +44.8% | |
| NEWAMSTERDAM PHARMA COMPANYordinary shares | $18,095,962 | -11.5% | 1,521,948 | 0.0% | 0.50% | -32.6% | ||
| VIGIL NEUROSCIENCE INC | $17,048,150 | -4.0% | 1,813,633 | 0.0% | 0.48% | -26.8% | ||
| GLYC | GLYCOMIMETICS INC | $16,607,016 | +38.1% | 9,544,262 | 0.0% | 0.46% | +5.2% | |
| STRO | SUTRO BIOPHARMA INC | $15,567,949 | +0.6% | 3,347,946 | 0.0% | 0.43% | -23.2% | |
| JASPER THERAPEUTICS INC | $13,563,000 | -24.3% | 9,900,000 | 0.0% | 0.38% | -42.3% | ||
| AN2 THERAPEUTICS INC | $13,293,686 | -13.9% | 1,563,963 | 0.0% | 0.37% | -34.2% | ||
| New | VERASTEM INC | $12,538,029 | – | 1,685,219 | +100.0% | 0.35% | – | |
| VERV | VERVE THERAPEUTICS INC | $12,187,500 | +30.0% | 650,000 | 0.0% | 0.34% | -0.9% | |
| CALT | CALLIDITAS THERAPEUTICS ABsponsered ads | $11,775,000 | -34.4% | 750,000 | 0.0% | 0.33% | -50.1% | |
| CTMX | CYTOMX THERAPEUTICS INC | $11,344,778 | +13.9% | 6,595,801 | 0.0% | 0.32% | -13.2% | |
| SLN | SILENCE THERAPEUTICS PLCads | $8,296,288 | -11.3% | 1,508,416 | 0.0% | 0.23% | -32.5% | |
| CDTX | CIDARA THERAPEUTICS INC | $7,753,074 | -11.0% | 6,861,127 | 0.0% | 0.22% | -32.3% | |
| New | TSCAN THERAPEUTICS INC | $7,473,685 | – | 2,989,474 | +100.0% | 0.21% | – | |
| DCTH | New | DELCATH SYS INC | $6,872,328 | – | 1,178,787 | +100.0% | 0.19% | – |
| NLSP | NLS PHARMACEUTICS LTD | $6,321,839 | -27.2% | 5,747,126 | 0.0% | 0.18% | -44.5% | |
| ARAV | ARAVIVE INC | $6,028,110 | -37.0% | 4,784,214 | 0.0% | 0.17% | -52.0% | |
| ELDN | Buy | ELEDON PHARMACEUTICALS INC | $5,927,593 | +8.0% | 4,326,710 | +86.0% | 0.16% | -17.9% |
| VIRX | VIRACTA THERAPEUTICS INC | $5,096,673 | -11.3% | 3,614,662 | 0.0% | 0.14% | -32.4% | |
| KRON | New | KRONOS BIO INC | $4,839,194 | – | 2,813,485 | +100.0% | 0.14% | – |
| RAIN | RAIN ONCOLOGY INC | $4,232,075 | -86.3% | 3,526,729 | 0.0% | 0.12% | -89.5% | |
| New | ASLAN PHARMACEUTICALS LTDspon ads new | $3,832,496 | – | 1,049,999 | +100.0% | 0.11% | – | |
| ELEV | ELEVATION ONCOLOGY INC | $3,514,544 | -20.0% | 2,312,200 | 0.0% | 0.10% | -39.1% | |
| PIRS | Buy | PIERIS PHARMACEUTICALS INC | $3,410,932 | -31.2% | 20,609,863 | +305.7% | 0.10% | -47.5% |
| CRVS | CORVUS PHARMACEUTICALS INC | $3,139,469 | +151.6% | 1,370,947 | 0.0% | 0.09% | +91.3% | |
| IMUX | IMMUNIC INC | $2,885,057 | +68.5% | 1,149,425 | 0.0% | 0.08% | +27.0% | |
| IVA | INVENTIVA SAads | $2,771,602 | +11.0% | 686,040 | 0.0% | 0.08% | -15.4% | |
| MOLN | MOLECULAR PARTNERS AGads | $2,708,080 | +1.8% | 443,221 | 0.0% | 0.08% | -22.7% | |
| MTEM | MOLECULAR TEMPLATES INC | $2,398,351 | +26.3% | 4,996,565 | 0.0% | 0.07% | -2.9% | |
| INFI | INFINITY PHARMACEUTICALS INC | $1,337,442 | +31.6% | 6,353,645 | 0.0% | 0.04% | 0.0% | |
| RZLT | REZOLUTE INC | $377,814 | +3.1% | 190,815 | 0.0% | 0.01% | -15.4% | |
| New | GALMED PHARMACEUTICALS LTD | $261,472 | – | 89,853 | +100.0% | 0.01% | – | |
| BIONOMICS LIMITEDads | $178,136 | -15.4% | 80,971 | 0.0% | 0.01% | -37.5% | ||
| GLMD | Exit | GALMED PHARMACEUTICALS LTD | $0 | – | -1,347,755 | -100.0% | -0.02% | – |
| ANGN | Exit | ANGION BIOMEDICA CORP | $0 | – | -1,071,297 | -100.0% | -0.02% | – |
| Exit | AADI BIOSCIENCE INC | $0 | – | -318,205 | -100.0% | -0.08% | – | |
| Exit | HILLEVAX INC | $0 | – | -248,579 | -100.0% | -0.15% | – | |
| VRDN | Exit | VIRIDIAN THERAPEUTICS INC | $0 | – | -168,000 | -100.0% | -0.16% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -858,339 | -100.0% | -0.24% | – |
| VSTM | Exit | VERASTEM INC | $0 | – | -19,022,656 | -100.0% | -0.29% | – |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -8,813,021 | -100.0% | -1.35% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -2,561,000 | -100.0% | -1.45% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -2,736,613 | -100.0% | -1.61% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -2,143,197 | -100.0% | -1.66% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
| 3 | 2023-11-06 |
| 4 | 2023-11-06 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.